Loading...
IL1RAP Platform Advancements And Strong Cash Runway Will Support Long Term Biotech Upside
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
124.8%7D
-8.8%1Y
124.8%7D
-8.8%You can edit this narrative until Dec 12 7:04 PM. Then, changes will post as Updates.